Yewei Zhang

Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas

Chonggao Wang, Yewei Zhang, Yewei Zhang, 2023, International journal of nanomedicine.

How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study.

Yanlong Shi, Yizhu Wang, Wenning Zhang, 2024, Computers in biology and medicine.

An intelligent DNA nanodevice for precision thrombolysis.

J. Chao, Yu Gao, Siyu Wang, 2024, Nature materials.

Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer

Xuanlong Du, Weilu Jia, Kun Feng, 2024, Signal transduction and targeted therapy.

O-GlcNAcylated RALY Contributes to Hepatocellular Carcinoma Cells Proliferation by Regulating USP22 mRNA Nuclear Export

Xuanlong Du, Wenjing Xu, Xinyu Mao, 2024, International Journal of Biological Sciences.

Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression

Kun Feng, Qingpeng Lv, Yewei Zhang, 2024, Signal transduction and targeted therapy.

An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness.

Hao Peng, Weilu Jia, Kun Feng, 2024, Apoptosis : an international journal on programmed cell death.

PHLDA2 reshapes the immune microenvironment and induces drug resistance in hepatocellular carcinoma

Kun Feng, Qingpeng Lv, Yewei Zhang, 2024, Oncology research.